FactorPad
Build a Better Process

Stock Risk Measures for Flexion Therapeutics Inc

A quantitative factor review as of September 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: October 05, 2021
See how we arrive at an overall risk score of 82 for FLXN below.

/ factorpad.com / stocks / f97kbw.html


An ad-free and cookie-free website.


FLXN Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Flexion Therapeutics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how FLXN stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Pharmaceutical Preparation Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f97kbw.html


FLXN stock risk
FLEXION THERAPEUTICS INC stock beta
FLXN risk report
FLXN f97kbw
FLXN risk analysis
FLXN volatility
FLEXION THERAPEUTICS INC credit risk
FLXN liquidity risk
FLXN leverage
FLXN valuation
FLXN systematic risk
FLXN specific risk
FLEXION THERAPEUTICS INC volatility
FLXN analysis
FLXN financial ratio

A newly-updated free resource. Connect and refer a friend today.